GlassScriptPhysician profile
Mohit Chhatpar
NPI 1578293635
$500.19
in general payments reported to CMS, 2019-2025
10 companies · $261 in 2025
The $261 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $13.33 · 2023: $98.75 · 2024: $127 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $487.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $486.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $124.98 | 2025 | Biktarvy |
| Sanofi-Aventis U.S. LLC | $111.72 | 2025 | |
| Astellas Pharma US INC | $96.95 | 2024 | Veozah |
| Novartis Pharmaceuticals Corporation | $39.96 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $30.72 | 2023 | Breztri |
| Janssen Biotech, INC. | $24.23 | 2025 | Tremfya |
| Csl Behring | $22.77 | 2023 | Kcentra |
| Sobi, INC | $21.70 | 2023 | |
| Cumberland Pharmaceuticals, INC. | $13.83 | 2024 | Vibativ |
| Janssen Pharmaceuticals, INC | $13.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohit Chhatpar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.